Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$9.56 USD
-0.03 (-0.31%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $9.55 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Lexeo Therapeutics, Inc. [LXEO]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Lexeo Therapeutics, Inc.
Industry: Medical - Drugs
Multiple 2H24 Catalysts Ahead; 2Q24 Financial Results; Decreasing PT to $21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Lexeo Therapeutics, Inc.
Industry: Medical - Drugs
Encouraging LX2006 Phase 1/2 Data; Higher Dose Cohort Added; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Lexeo Therapeutics, Inc.
Industry: Medical - Drugs
Heart and CNS Gene Therapy; 2024 Catalyst Trifecta; Initiate at Buy and $22 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
|